Catalogue peptides cover common research sequences, but research often calls for something specific that is not on the shelf: a defined sequence, a particular modification, a chosen scale. Custom peptide synthesis fills that gap. Understanding the workflow helps a research team submit a clear request and set realistic expectations on purity, scale and lead time.

Solid-phase peptide synthesis in brief

Most custom peptides are built using solid-phase peptide synthesis (SPPS). The growing chain is anchored to an insoluble resin support, and amino acids are added one at a time in a repeating cycle of coupling and deprotection. Building on a solid support means excess reagents and by-products can simply be washed away at each step. Once the full sequence is assembled, the peptide is cleaved from the resin, purified and freeze-dried.

What to specify in a request

• Sequence: the amino-acid sequence, noting any non-standard residues, cyclisation or other structural features.
• Purity grade: common research targets are >95%, >98% or ≥99% by HPLC; higher purity generally means more purification and a higher price.
• Scale: milligram quantities for early work, gram scale for larger research programmes.
• Modifications: terminal capping, labels, conjugates or a particular counter-ion / salt form.

The typical workflow

• 1 · Request & feasibility: you submit the sequence, scale and purity target; the synthesiser returns a feasibility note, price and lead time. Some sequences — very long, highly hydrophobic or heavily modified — are more challenging and this is flagged up front.
• 2 · Synthesis: the chain is assembled by SPPS.
• 3 · Cleavage & purification: the peptide is released from the resin and purified, usually by preparative HPLC, to the requested grade.
• 4 · Quality control: the finished material is verified by HPLC for purity and mass spectrometry for identity.
• 5 · Delivery: the peptide ships as a lyophilized powder with a per-lot Certificate of Analysis.

Factors that affect price and lead time

Length is the first driver — every additional residue adds coupling cycles. Difficult sequences, non-standard residues, special modifications and higher purity grades all add steps. Larger scales require more raw material. A clear, complete request lets a synthesiser quote accurately and avoids back-and-forth that lengthens the timeline.

Getting it right the first time

Double-check the sequence before submitting — a single transposed residue produces a different molecule. State the purity grade explicitly rather than leaving it implied, and mention the intended research context only insofar as it affects format (for instance, the preferred salt form). With a precise brief, custom synthesis reliably turns a sequence on paper into a verified vial of research material.

Custom-synthesised peptides are supplied as research-grade reference materials for laboratory use only and are not for human or animal consumption.

On the surface, research peptide suppliers can look interchangeable: similar product lists, the same ≥99% figures, comparable pricing. The meaningful differences are not in the headline numbers but in how a supplier proves and documents those numbers. For laboratories and distributors, a short evaluation framework separates dependable partners from the rest.

Independent third-party testing

An in-house purity claim is a starting point, not a guarantee. The stronger signal is independent third-party analysis: a recognised external laboratory verifying identity and purity. Ask whether reports come from a named external lab and whether those reports can be viewed directly, rather than only as a supplier-typed summary. Independent verification is the foundation everything else rests on.

Batch traceability

Every lot should carry a batch number that links the physical vial to its specific Certificate of Analysis. This traceability lets a receiving laboratory confirm that the document in hand actually describes the powder in front of them. A supplier that maintains a browsable library of certificates, indexed by batch, is demonstrating that traceability is built into their process rather than assembled on request.

What complete documentation looks like

• Identity confirmed by mass spectrometry, matched to the published molecular weight.
• Purity reported from an HPLC chromatogram, with the chromatogram included.
• Net peptide content stated alongside chromatographic purity.
• Salt form and, where relevant, water content reported.
• A batch number tying it all to the physical lot.

Consistency across batches

A single good certificate is encouraging; consistency across many lots is what builds confidence. If you can review historical certificates and see stable results batch after batch, that track record is more reassuring than any one impressive report. Suppliers confident in their process tend to make this history easy to access.

Logistics and handling

Documentation aside, evaluate the practical side: are compounds shipped with appropriate insulated packaging and cold-chain measures? Are storage conditions and specifications clearly published for each product? Mishandling in transit can undermine an otherwise excellent lot, so a supplier’s shipping discipline is part of the quality picture.

A compact evaluation checklist

• Is testing independent and from a named laboratory?
• Can certificates be viewed directly and matched by batch number?
• Do reports cover identity, purity and net content?
• Is there a consistent history across multiple lots?
• Are storage, specifications and shipping clearly documented?

Run a prospective supplier through these questions and the ones worth a long-term relationship quickly stand out.

This article concerns the sourcing of research-grade reference materials for laboratory use only. Such materials are not for human or animal consumption.

Alongside single-compound vials, research catalogues increasingly list blended formulas: a single lyophilized preparation containing several peptides in a fixed ratio. Products such as multi-component tissue-research blends fall into this category. For distributors deciding what to stock, it helps to understand how blends differ from single compounds and what documentation to expect.

What a blend actually is

A blend is several characterised research peptides combined into one vial at a defined ratio. A three-part formula might pair complementary research peptides; a four-part formula adds a further component. The appeal is convenience — one vial provides a fixed, repeatable multi-component reference rather than requiring a laboratory to combine separate stocks each time.

Documentation differences

A single compound has one molecular weight, one CAS number and one straightforward purity figure. A blend is documented differently:

• There is no single molecular weight or CAS number for the mixture as a whole.
• Purity is best reported per component, since each peptide is verified individually.
• The ratio between components should be stated and consistent batch to batch.

When evaluating a blend, look for a Certificate of Analysis that addresses each constituent rather than a single combined number. A blend that only reports one figure is harder to verify.

Handling and reconstitution

Blends reconstitute much like single compounds — typically in sterile or bacteriostatic water — but the total milligram figure refers to the combined mass of all components. A 70mg or 80mg blend is divided across its constituents according to the stated ratio, so the amount of any individual peptide is a fraction of the total. Keep that in mind when calculating working concentrations.

Inventory considerations for distributors

• Clarity of labelling: the components and total milligram figure should be unambiguous on the listing.
• Batch consistency: the ratio should not drift between lots.
• Per-component testing: documentation should cover each peptide.
• Storage: the same −20°C, sealed, dark, dry rules apply as for single compounds.

Choosing between the two

Single compounds offer maximum flexibility and the simplest documentation. Blends offer convenience and a fixed multi-component reference. Many catalogues carry both, and stocking a small range of well-documented blends alongside the core single-compound list lets a distributor serve laboratories that want either approach.

All single compounds and blends referenced are research-grade reference materials for laboratory use only and are not for human or animal consumption.